D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$728M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$625M |
| 3 |
Merck
MRK
|
+$498M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Fortinet
FTNT
|
+$321M |
Top Sells
| 1 |
Tesla
TSLA
|
+$696M |
| 2 |
Adobe
ADBE
|
+$610M |
| 3 |
Accenture
ACN
|
+$518M |
| 4 |
Microsoft
MSFT
|
+$495M |
| 5 |
Broadcom
AVGO
|
+$471M |
Sector Composition
| 1 | Technology | 22.95% |
| 2 | Consumer Discretionary | 14.11% |
| 3 | Healthcare | 10.4% |
| 4 | Financials | 9.83% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Ultra Clean Holdings
UCTT
$1.16B
| $9.09M | 0.01% |
+227,685
| New | +$9.09M |
|
877
Sandstorm Gold
SAND
$3.44B
| $9.07M | 0.01% |
1,511,560
+1,310,453
| +652% | +$7.86M |
|
878
CSG Systems International
CSGS
$1.89B
| $9.03M | 0.01% |
185,688
-82,353
| -31% | -$4.01M |
|
879
US Foods
USFD
$18B
| $9.02M | 0.01% |
146,608
+66,893
| +84% | +$4.11M |
|
880
Chegg
CHGG
$173M
| $8.99M | 0.01% |
5,079,781
+135,863
| +3% | +$240K |
|
881
Viatris
VTRS
$11.9B
| $8.96M | 0.01% |
771,991
-152,702
| -17% | -$1.77M |
|
882
Paychex
PAYX
$48.7B
| $8.93M | 0.01% |
66,562
-28,296
| -30% | -$3.8M |
|
|
SMAR
883
DELISTED
Smartsheet Inc.
SMAR
| $8.93M | 0.01% |
161,222
-249,860
| -61% | -$13.8M |
|
884
Kymera Therapeutics
KYMR
$3.3B
| $8.91M | 0.01% |
188,197
-107,375
| -36% | -$5.08M |
|
885
Murphy USA
MUSA
$7.59B
| $8.9M | 0.01% |
18,056
-1,553
| -8% | -$765K |
|
886
Axogen
AXGN
$773M
| $8.89M | 0.01% |
634,344
+25,759
| +4% | +$361K |
|
|
LGF.B
887
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $8.84M | 0.01% |
1,276,845
+260,755
| +26% | +$1.8M |
|
888
TKO Group
TKO
$16.6B
| $8.83M | 0.01% |
+71,405
| New | +$8.83M |
|
889
Summit Therapeutics
SMMT
$13.8B
| $8.81M | 0.01% |
402,167
+372,467
| +1,254% | +$8.16M |
|
890
RE/MAX Holdings
RMAX
$199M
| $8.77M | 0.01% |
704,521
+1,093
| +0.2% | +$13.6K |
|
891
Prudential
PUK
$35.8B
| $8.76M | 0.01% |
472,373
-189,469
| -29% | -$3.51M |
|
892
Jacobs Solutions
J
$17.8B
| $8.73M | 0.01% |
67,393
+43,443
| +181% | +$5.63M |
|
893
Weatherford International
WFRD
$4.51B
| $8.73M | 0.01% |
102,758
+49,527
| +93% | +$4.21M |
|
894
Heron Therapeutics
HRTX
$196M
| $8.73M | 0.01% |
4,384,677
+521,302
| +13% | +$1.04M |
|
895
MediaAlpha
MAX
$684M
| $8.7M | 0.01% |
480,571
+35,897
| +8% | +$650K |
|
896
Cirrus Logic
CRUS
$5.91B
| $8.68M | 0.01% |
69,921
-41,347
| -37% | -$5.14M |
|
897
Aecom
ACM
$16.9B
| $8.68M | 0.01% |
84,095
-25,599
| -23% | -$2.64M |
|
|
GPAT
898
GP-Act III Acquisition Corp. Class A Ordinary Share
GPAT
$380M
| $8.67M | 0.01% |
+859,773
| New | +$8.67M |
|
|
NVRO
899
DELISTED
NEVRO CORP.
NVRO
| $8.65M | 0.01% |
1,546,589
+400,359
| +35% | +$2.24M |
|
900
Bankunited
BKU
$2.96B
| $8.61M | 0.01% |
236,310
-219,308
| -48% | -$7.99M |
|